Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
Spirito A, Cohen R, Sartori S, Vogel B, Baber U, Pileggi B, Smith K, Nicosia D, Kamaleldin K, Farhan S, Kini A, Sharma SK, Dangas G, Mehran R. Spirito A, et al. Among authors: kamaleldin k. Catheter Cardiovasc Interv. 2024 Feb;103(3):425-434. doi: 10.1002/ccd.30960. Epub 2024 Feb 5. Catheter Cardiovasc Interv. 2024. PMID: 38314901
Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset.
Spirito A, Nussbaum J, Sartori S, Vogel B, Abizaid A, Cao D, Christiansen EH, Colombo A, de Winter RJ, Haude M, Kamaleldin K, Jakobsen L, Jensen LO, Krucoff MW, Landmesser U, Nardin M, Saito S, Smith KF, Suryapranata H, De Luca G, Dangas G, Mehran R; Mega-COMBO Collaboration. Spirito A, et al. Among authors: kamaleldin k. Am J Cardiol. 2023 Dec 15;209:52-54. doi: 10.1016/j.amjcard.2023.09.081. Epub 2023 Oct 20. Am J Cardiol. 2023. PMID: 37866281 No abstract available.
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry.
Spirito A, Cao D, Sartori S, Sharma A, Smith KF, Vogel B, Kamaleldin K, Koshy AN, Feng Y, Power D, Baber U, Krishnamoorthy P, Dangas G, Kini A, Sharma SK, Mehran R. Spirito A, et al. Among authors: kamaleldin k. Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):11-19. doi: 10.1093/ehjcvp/pvad069. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 37742213
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.
Spirito A, Koh WJ, Sartori S, Vogel B, Feng Y, Baber U, Nicolas J, Snyder C, Kamaleldin K, Pileggi B, Rezvanizadeh V, Sweeny J, Sharma SK, Kini A, Pocock SJ, Dangas G, Mehran R. Spirito A, et al. Among authors: kamaleldin k. Am Heart J. 2023 Sep;263:26-34. doi: 10.1016/j.ahj.2023.04.007. Epub 2023 Apr 23. Am Heart J. 2023. PMID: 37094668
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
Chen H, Spirito A, Sartori S, Nicolas J, Cao D, Zhang Z, Baber U, Kamaleldin K, Guthrie J, Vogel B, Sweeny J, Krishnan P, Sharma SK, Kini A, Dangas G, Mehran R. Chen H, et al. Among authors: kamaleldin k. Catheter Cardiovasc Interv. 2023 Feb;101(3):511-519. doi: 10.1002/ccd.30569. Epub 2023 Jan 24. Catheter Cardiovasc Interv. 2023. PMID: 36691863